Regulations.gov document
Petition for Stay from Buchanan Ingersoll & Rooney PC on behalf of Breckenridge…
Other · FDA-2008-N-0549 · posted Apr 9, 2018
Key facts
| Document ID | FDA-2008-N-0549-0046 |
|---|---|
| Title | Petition for Stay from Buchanan Ingersoll & Rooney PC on behalf of Breckenridge Pharmaceutical, Inc and Nexgen Pharma, Inc. |
| Document type | Other |
| Subtype | Petition(s) |
| Agency | FDA |
| Docket | FDA-2008-N-0549 |
| Posted | Apr 9, 2018 |
| Comment period opens | Apr 9, 2018 |
| Comments due | Apr 14, 2018 |
At a glance
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: